|
|
|
|
| LEADER |
00000cam a2200000Mu 4500 |
| 001 |
EBOOKCENTRAL_ocn940510409 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
160227s1990 dcu o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCQ
|d XFH
|d OCLCO
|d ZCU
|d OCLCO
|d MERUC
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCA
|d ICG
|d OCLCO
|d OCLCF
|d OCLCQ
|d OCLCO
|d AU@
|d OCLCO
|d OCLCQ
|d OCLCO
|d DKC
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCL
|d OCLCQ
|d OCLCA
|d OCLCQ
|d OCLCA
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCL
|d OCLCO
|d OCLCL
|
| 020 |
|
|
|a 9780309555975
|
| 020 |
|
|
|a 0309555973
|
| 029 |
1 |
|
|a DEBBG
|b BV044107653
|
| 035 |
|
|
|a (OCoLC)940510409
|
| 050 |
|
4 |
|a QR189.5.P46
|b I56 1991eb
|
| 082 |
0 |
4 |
|a 615/.372
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Howson, Christopher P.
|
| 245 |
1 |
0 |
|a Adverse Effects of Pertussis and Rubella Vaccines.
|
| 260 |
|
|
|a Washington :
|b National Academies Press,
|c 1990.
|
| 300 |
|
|
|a 1 online resource (381 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Adverse Effects of Pertussis and Rubella Vaccines; Copyright; Preface; Acknowledgments; Contents; Adverse Effects of PERTUSSIS and RUBELLA Vaccines; 1 Executive Summary ; METHODOLOGIC CONSIDERATIONS IN EVALUATING THE EVIDENCE; SUMMARY AND CONCLUSIONS; RESEARCH NEEDS; 2 Histories of Pertussis and Rubella Vaccines ; PERTUSSIS VACCINES; Epidemiology of Whooping Cough; Clinical Description; Diagnosis; Complications; Descriptive Epidemiology; Nature of the Causative Organism, B. pertussis; Major Milestones in the Development of Pertussis Vaccines; Whole-Cell Vaccines; Acellular Vaccines.
|
| 505 |
8 |
|
|a Brief History of the Controversy Pertaining to Adverse Events Following Pertussis VaccinationRUBELLA VACCINES; Epidemiology of the Disease Rubella; Clinical Description; Diagnosis; Complications; Descriptive Epidemiology; Nature of the Rubella Virus; Major Milestones in the Development of Rubella Vaccines; Brief History of the Controversy Pertaining to Adverse Events Following Rubella Vaccination; REFERENCES; 3 Methodologic Considerations in Evaluating the Evidence ; THE NATURE OF THE EVIDENCE; QUESTIONS TO BE ADDRESSED; (1) Can vaccine cause the adverse event?
|
| 505 |
8 |
|
|a (2) How frequently does vaccine cause the event?(3) Did vaccination cause a particular case of the adverse event?; THE BURDEN OF PROOF; CATEGORIES OF EVIDENCE; Experiments in Humans; Randomized Controlled Trials; Other Experimental Studies; Experiments in Animals: Animal Models; Controlled Epidemiologic Studies (Observational); Cohort Studies; Case-Comparison Studies; Other Controlled Studies; Case Reports and Case Series; Searching for Patterns; Historical Comparisons; Causation of the Individual Case; Monitoring System for Adverse Events Following Immunization; ASSESSMENT OF THE EVIDENCE.
|
| 505 |
8 |
|
|a Evaluation of Single StudiesIntegration of the Collective Results; Meta-Analysis; Considerations in Inferring Causality; THE NATURE OF THE CONCLUSIONS; Quantitation; Resolution; Uncertainty and Confidence; Quality; Comprehensiveness; Neutrality; Judgment; SUMMARY OF THE EVIDENCE; REFERENCES; 4 Evidence Concerning Pertussis Vaccines and Central Nervous System Disorders, Including Infantile ... ; INFANTILE SPASMS; Clinical Description; Descriptive Epidemiology; History of Suspected Association with Pertussis Vaccines; Evidence from Studies in Humans; Case Reports and Case Series.
|
| 505 |
8 |
|
|a Controlled Epidemiologic StudiesSummary; Conclusion; HYPSARRHYTHMIA; Clinical Description; Descriptive Epidemiology; History of Suspected Association with Pertussis Vaccines; Evidence from Studies in Humans; Case Reports and Case Series; Controlled Epidemiologic Studies; Summary; Conclusion; ASEPTIC MENINGITIS; Clinical Description; Descriptive Epidemiology; History of Suspected Association with Pertussis Vaccines; Evidence from Studies in Humans; Case Reports and Case Series; Controlled Epidemiologic Studies; Summary; Conclusion; ENCEPHALOPATHY; Clinical Description.
|
| 500 |
|
|
|a Encephalopathy Following Whooping Cough.
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Pertussis vaccines
|x Side effects
|v Congresses.
|
| 650 |
|
0 |
|a Rubella vaccines
|x Side effects
|v Congresses.
|
| 650 |
|
0 |
|a Whooping cough
|x Vaccination
|x Complications
|v Congresses.
|
| 650 |
|
0 |
|a Rubella
|x Vaccination
|x Complications
|v Congresses.
|
| 650 |
|
0 |
|a Viral vaccines.
|
| 650 |
|
0 |
|a Vaccines.
|
| 650 |
|
0 |
|a Bacterial vaccines.
|
| 650 |
|
0 |
|a Pertussis vaccines.
|
| 650 |
|
0 |
|a Rubella vaccines.
|
| 650 |
|
0 |
|a Biological products.
|
| 650 |
|
0 |
|a Biologicals.
|
| 650 |
|
2 |
|a Biological Products
|
| 650 |
|
2 |
|a Viral Vaccines
|
| 650 |
|
2 |
|a Vaccines
|
| 650 |
|
2 |
|a Bacterial Vaccines
|
| 650 |
|
2 |
|a Complex Mixtures
|
| 650 |
|
2 |
|a Chemicals and Drugs
|
| 650 |
|
2 |
|a Pertussis Vaccine
|
| 650 |
|
2 |
|a Rubella Vaccine
|
| 650 |
|
2 |
|a Biological Factors
|
| 650 |
|
6 |
|a Vaccins anticoquelucheux
|x Effets secondaires
|v Congrès.
|
| 650 |
|
6 |
|a Vaccins antirubéoleux
|x Effets secondaires
|v Congrès.
|
| 650 |
|
6 |
|a Coqueluche
|x Vaccination
|x Complications et séquelles
|v Congrès.
|
| 650 |
|
6 |
|a Rubéole
|x Vaccination
|x Complications et séquelles
|v Congrès.
|
| 650 |
|
6 |
|a Vaccins antiviraux.
|
| 650 |
|
6 |
|a Vaccins.
|
| 650 |
|
6 |
|a Vaccins antibactériens.
|
| 650 |
|
6 |
|a Vaccins anticoquelucheux.
|
| 650 |
|
6 |
|a Vaccins antirubéoleux.
|
| 650 |
|
6 |
|a Produits biologiques.
|
| 650 |
|
6 |
|a Médicaments biologiques.
|
| 650 |
|
7 |
|a Viral vaccines
|2 fast
|
| 650 |
|
7 |
|a Vaccines
|2 fast
|
| 650 |
|
7 |
|a Rubella vaccines
|2 fast
|
| 650 |
|
7 |
|a Pertussis vaccines
|2 fast
|
| 650 |
|
7 |
|a Biologicals
|2 fast
|
| 650 |
|
7 |
|a Biological products
|2 fast
|
| 650 |
|
7 |
|a Bacterial vaccines
|2 fast
|
| 650 |
|
7 |
|a Whooping cough
|x Vaccination
|x Complications
|2 fast
|
| 655 |
|
7 |
|a Conference papers and proceedings
|2 fast
|
| 700 |
1 |
|
|a Howe, Cynthia J.
|
| 700 |
1 |
|
|a Fineberg, Harvey V.
|
| 758 |
|
|
|i has work:
|a Adverse effects of pertussis and rubella vaccines (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCGffmp3KQ6wCkXDWPDPwBX
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
| 776 |
0 |
8 |
|i Print version:
|a Howson, Christopher P.
|t Adverse Effects of Pertussis and Rubella Vaccines.
|d Washington : National Academies Press, ©1990
|z 9780309044998
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=3376957
|z Texto completo
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL3376957
|
| 994 |
|
|
|a 92
|b IZTAP
|
